Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02616 CSTONE PHARMA-B
RT Nominal down5.755 -0.325 (-5.345%)
Latest  |  Final  |  Interim
Non-current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/06
RMB(K¥)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others73,439-4.683%88,624100,428130,169162,056
Land & other Lease Assets16,525171.748%21,36130,57949,26587,109
Intangible Assets143,847-3.901%155,526167,206217,474173,881
Interests in Asso. & JCEs0--0000
Other Non-current Assets14,53517.550%24,90515,61228,63114,941

248,3461.291%290,416313,825425,539437,987
Current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/06
RMB(K¥)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
Inventories74,174-36.542%148,851181,53019,57653,900
Trade Receivables107,358217.524%62,536179,094185,867164,027
Cash & Bank Balances1,395,24885.120%457,766678,856906,224731,458
Other Current Assets230,86910.574%232,336178,794122,528627,350
Assets Held for Sale0--0000

1,807,64962.385%901,4891,218,2741,234,1951,576,735
Current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/06
RMB(K¥)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
Trade Payables99,03528.282%212,085245,042342,35073,992
S-T Debt & Leases167,622-12.509%219,94798,32441,83674,321
Other Current Liabilities237,965-1.437%193,764369,831418,917752,314
Liab asso w/ Assets Held for Sale0--0000

504,622-1.098%625,796713,197803,103900,627
Net Current Assets1,303,027116.103%275,693505,077431,092676,108
Total Assets Less Current Liabilities1,551,37382.914%566,109818,902856,6311,114,095
Non-current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/06
RMB(K¥)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
L-T Debt & Leases189,61620.829%171,426236,344177,735162,471
Other Non-current Liabilities69,254-6.975%79,639114,90275,1811,022

258,87011.883%251,065351,246252,916163,493
Capital and Reserves
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/06
RMB(K¥)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
  Share Capital1,0848.617%918860860797
  Reserves1,291,419109.724%314,126466,796602,855949,805
  Others0--0000
Shareholders' Funds1,292,503109.560%315,044467,656603,715950,602
Non-controlling Interests0--0000
Others0--0000

1,292,503109.560%315,044467,656603,715950,602
Commitments and Contingent Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/06
RMB(K¥)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
Commitments------------
Contingent Liabilities------------
Remarks:  Real time quote last updated: 11/09/2026 09:49
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB -252,284
%Change-6.625%
EPS / (LPS)RMB -0.170
NBV Per Share (¥)RMB 0.807
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.